当前位置:首页 - 行情中心 - 迈威生物-U(688062) - 财务分析

迈威生物-U

(688062)

  

流通市值:72.21亿  总市值:141.34亿
流通股本:2.04亿   总股本:4.00亿

迈威生物-U(688062)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年第一季度实现净利润-2.06亿元,每股收益-0.51元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年第一季度最新股东权益239570.35万元,未分配利润-395700.80万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年第一季度最新总资产464181.53万元,负债224611.18万元。

利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入67,555,138.51127,835,534.4299,511,384.0489,961,372.07
营业总成本282,657,001.661,175,894,797.97775,388,223.53505,087,817.6
营业利润-206,210,659.08-1,052,579,065.57-675,112,139.5-414,357,391.95
利润总额-206,210,666.06-1,055,287,603.71-676,041,100.24-415,364,379.05
净利润-206,210,666.06-1,058,811,365.59-676,619,021.82-415,942,300.63
其他综合收益123,084.63,244,278.374,789,781.455,581,924.53
综合收益总额-206,087,581.46-1,055,567,087.22-671,829,240.37-410,360,376.1
资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计2,217,103,319.762,047,592,313.462,149,595,299.692,400,226,320.87
非流动资产合计2,424,711,971.392,407,456,127.252,300,936,850.962,250,370,604.96
资产总计4,641,815,291.154,455,048,440.714,450,532,150.654,650,596,925.83
流动负债合计1,051,476,382.89816,386,767.78511,472,300.09500,327,738.55
非流动负债合计1,194,635,453.111,065,413,609.681,024,907,127.59996,526,017.48
负债合计2,246,111,8361,881,800,377.461,536,379,427.681,496,853,756.03
归属于母公司股东权益合计2,406,709,424.562,583,701,890.992,922,560,368.13,161,235,553.82
股东权益合计2,395,703,455.152,573,248,063.252,914,152,722.973,153,743,169.8
负债和股东权益合计4,641,815,291.154,455,048,440.714,450,532,150.654,650,596,925.83
现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计90,544,176.33292,707,770.69226,168,080.81196,178,040.44
经营活动现金流出小计421,141,114.361,075,436,050.03788,626,939.35517,526,821.88
经营活动产生的现金流量净额-330,596,938.03-782,728,279.34-562,458,858.54-321,348,781.44
投资活动现金流入小计107,716,644.21496,718,038.74280,841,968.42228,302,234.89
投资活动现金流出小计283,505,565.221,006,340,829.04732,547,641.13606,375,188.02
投资活动产生的现金流量净额-175,788,921.01-509,622,790.3-451,705,672.71-378,072,953.13
筹资活动现金流入小计1,360,160,000612,096,391.06431,300,191.33382,688,698.3
筹资活动现金流出小计775,719,243.89167,160,272.85102,801,617.4589,480,353.05
筹资活动产生的现金流量净额584,440,756.11444,936,118.21328,498,573.88293,208,345.25
汇率变动对现金及现金等价物的影响13,974.421,403,497.515,468,826.231,987,278.08
现金及现金等价物净增加额78,068,871.49-846,011,453.92-680,197,131.14-404,226,111.24
期末现金及现金等价物余额1,721,702,106.251,643,633,234.761,809,447,557.542,085,418,577.44
最新报告期:2024-04-19
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国信证券张佳博,陈曦炳,陈益凌-1.87-1.29-0.322024-04-19
广发证券李安飞,罗佳荣-2.72-1.63-0.172024-04-18
德邦证券李霁阳-2.25-1.58-0.402024-04-17
华金证券赵宁达-2.43-1.43-0.162024-04-13
西部证券徐子悦,李梦园-2.05-0.78--2024-03-20
TOP↑